Sindy Liao-Chan
Atara Biotherapeutics (United States)
ORCID: 0000-0002-6606-0247MedicineImmunology and Microbiology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 1 paper. Top paper: “Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers”.
N/A
77 citations
Iga Kucharska, Yong Zi Tan, Samir Benlekbir, Hong Cui, Tiantian Zhao +21 more